Brief: Actinium Pharmaceuticals Announces Pricing Of $25 Mln Public Offering
17/06/2020 06:22
June 17 (Reuters) - Actinium Pharmaceuticals Inc ATNM.A :
* ACTINIUM PHARMACEUTICALS, INC. ANNOUNCES PRICING OF $25.0
MILLION PUBLIC OFFERING
* PUBLIC OFFERING OF 76,923,077 SHARES OF ITS COMMON STOCK
AT
$0.325 PER SHARE OF COMMON STOCK
* AGGREGATE GROSS PROCEEDS FROM OFFERING ARE EXPECTED TO BE
APPROXIMATELY $25.0 MILLION
Source text for Eikon: ID:nPn89Bykqa
Further company coverage: ATNM.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actinium Pharmaceuticals
See all newsBrief: Actinium Pharmaceuticals - Receives Two Canadian Patent Allowances For Actimab-A And Iomab-Act Programs
Brief: ctinium’s Atnm-400 Shows Strong Efficacy in TNBC, Beats Therapy Resistance at SABCS
Brief: Actinium Pharmaceuticals Says ATNM-400 Shows Superior Efficacy To Xtandi In Prostate Cancer
Brief: Actinium Pharmaceuticals Announces ATNM-400 A Novel Non-PSMA Targeting First In Class Prostate Cancer Radiotherapy Leveraging Actinium-225
Brief: Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development Activities